Drug Trial Radar · NCT00278746
Addition of Zinc to the Current Case Management Package of Diarrhea in a Primary Health Care Setting
Last checked: Nov 19, 2026Latest source record: Jun 16, 2015 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
20,032
Actual
Start
Jan 2005
Primary completion
Sep 2006
Study completion Sep 2006
Sponsor
- Lead sponsor
- Society for Applied StudiesAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Ministry of Science and Technology, India; United Nations Children's Fund, Delhi; World Health Organization
- First posted
- Jan 18, 2006
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 1 month, up to 5 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Several studies have shown the beneficial effect of zinc treatment in acute diarrhea. There was a significant reduction in duration of the treated episodes and in their severity as measured by diarrheal stool output or frequency. Zinc is a potentially important immunomodulator or nutraceutical which may have great impact as therapeutic agent in conditions like diarrhea and pneumonia. The issue is whether and how zinc should be introduced in primary health care programs for treatment of acute diarrhea. A practical, sustainable intervention for introduction of zinc as treatment of acute diarrhoea in national programs is therefore required. This study aimed to address this issue.
Conditions
- Diarrhea
- Mortality
- Hospitalization
Interventions
Zinc and ORSDrug
Government and private providers and village health workers were trained to prescribe zinc and ORS for use in diarrheal episodes in 1 month to 5 years old children in intervention communities
ORS onlyDrug
Promoted routine management of diarrhea in underfive with ORS
Primary outcomes
What the sponsor says the trial is designed to measure.
- To evaluate in a community based controlled effectiveness trial whether addition of zinc as a therapeutic modality for diarrhea delivered through existing channels, including at village level to the current case management package for under-five childrenTime frame: 20 months (Jan 2005 to Sep 2006)
- - Reduction in visits to health care providers for treatment of illnessTime frame: 20 months (Jan 2005 to Sep 2006)
- - Reduction in drug use; antibiotics and other drugs during diarrheal illnessesTime frame: 20 months (Jan 2005 to Sep 2006)
- - Increase in ORS use during diarrhea in the intervention communities.Time frame: 20 months (Jan 2005 to Sep 2006)
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Society for Applied Studies
New Delhi, National Capital Territory of Delhi, India
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.